Neuroimaging of demyelination and remyelination models

Current Topics in Microbiology and Immunology

Volumn 318, Issue , 2008, Pages 241-266

  Pirko, I ^a   Johnson, A J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA INTEGRIN; CHIMERIC PROTEIN; CONTRAST MEDIUM; DEFEROXAMINE; GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE ALBUMIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; ROLIPRAM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ALLERGIC ENCEPHALOMYELITIS; BIOLOGICAL MONITORING; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; DEMYELINATION; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISABILITY; DISEASE SEVERITY; ENCEPHALITIS; EXPERIMENTAL MODEL; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAPSE; REMYELINIZATION; REVIEW; SIGNAL NOISE RATIO; ANIMAL; BRAIN; DISEASE MODEL; GUINEA PIG; MOUSE; MYELIN SHEATH; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; RAT; SPINAL CORD;

ANIMALIA; RODENTIA;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GUINEA PIGS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; RATS; SPINAL CORD;

EID: 39549115884     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-73677-6_10     Document Type: Review

References (66)

1. Ahrens ET, Laidlaw DH, Readhead C, Brosnan CF, Fraser SE, Jacobs RE (1998) Mr microscopy of transgenic mice that spontaneously acquire experimental allergic encephalomyelitis. Magn Reson Med 40:119-132
2. Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P (2003) Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60:1073-1081
3. Biton IE, Mayk A, Kidron D, Assaf Y, Cohen Y (2005) Improved detectability of experimental allergic encephalomyelitis in excised swine spinal cords by high b-value q-space DWI. Exp Neurol 195:437-446
4. Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, Landon DN, McDonald WI (1993) The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 29:737-745
5. Cook LL, Foster PJ, Karlik SJ (2005) Pathology-guided MR analysis of acute and chronic experimental allergic encephalomyelitis spinal cord lesions at 1.5 T. J Magn Reson Imaging 22:180-188
6. Cook LL, Foster PJ, Mitchell JR, Karlik SJ (2004) In vivo 4.0-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis. J Magn Reson Imaging 20:563-571
7. Deloire-Grassin MS, Brochet B, Quesson B, Delalande C, Dousset V, Canioni P, Petry KG (2000) In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci 178:10-16
8. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM (1999) Dose and scanning delay using USPIO for central nervous system macrophage imaging. Magma 8:185-189
9. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, Lavi E, Cohen JA (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182:483-491
10. Duckers HJ, Muller HJ, Verhaagen J, Nicolay K, Gispen WH (1997) Longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: effect of a neurotrophic treatment on cortical lesion development. Neuroscience 77:1163-1173
11. Floris S, Blezer EL, Schreibelt G, Dopp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE (2004) Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127:616-627
12. Gareau PJ, Rutt BK, Karlik SJ, Mitchell JR (2000) Magnetization transfer and multicomponent t2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 11:586-595
13. Gareau PJ, Wymore AC, Cofer GP, Johnson GA (2002) Imaging inflammation: direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy. J Magn Reson Imaging 16:28-36
14. Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL (1994) In healthy primates, circulating autoreactive t cells mediate autoimmune disease. J Clin Invest 94:1339-1345
15. Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a camp-specific phosphodiesterase inhibitor. Proc Natl Acad Sci U S A 92:3601-3605
16. Grossman RI, Lisak RP, Macchi PJ, Joseph PM (1987) MR of acute experimental allergic encephalomyelitis. AJNR Am J Neuroradiol 8:1045-1048
17. Guy J, Fitzsimmons J, Ellis EA, Beck B, Mancuso A (1992) Intraorbital optic nerve and experimental optic neuritis. Correlation of fat suppression magnetic resonance imaging and electron microscopy. Ophthalmology 99:720-725
18. Guy J, Fitzsimmons J, Ellis EA, Mancuso A (1990) Gadolinium-DTPA-enhanced magnetic resonance imaging in experimental optic neuritis. Ophthalmology 97:601-607
19. Guy J, McGorray S, Fitzsimmons J, Beck B, Mancuso A, Rao NA, Hamed L (1994) Reversals of blood-brain barrier disruption by catalase: a serial magnetic resonance imaging study of experimental optic neuritis. Invest Ophthalmol Vis Sci 35:3456-3465
20. Guy J, McGorray S, Qi X, Fitzsimmons J, Mancuso A, Rao N (1994) Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis. Ophthalmic Res 26:310-323
21. Hawkins CP, Mackenzie F, Tofts P, du Boulay EP, McDonald WI (1991) Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 114:801-810
22. Hawkins CP, Munro PM, Landon DN, McDonald WI (1992) Metabolically dependent blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 83:630-635
23. Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS, du Boulay EP, Landon DN, McDonald WI (1990) Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 113:365-378
24. Heide AC, Richards TL, Alvord EC Jr, Peterson J, Rose LM (1993) Diffusion imaging of experimental allergic encephalomyelitis. Magn Reson Med 29:478-484
25. Karlik SJ, Grant EA, Lee D, Noseworthy JH (1993) Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig. Magn Reson Med 30:326-331
26. Karlik SJ, Munoz D, St Louis J, Strejan G (1999) Correlation between MRI and clinicopathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein. Magn Reson Imaging 17:731-737
27. Karlik SJ, Wong C, Gilbert JJ, Noseworthy JH (1989) NMR studies in the relapsing experimental allergic encephalomyelitis (EAE) model of multiple sclerosis in the strain 13 guinea pig. Magn Reson Imaging 7:463-473
28. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK (2006) Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21:626-632
29. Kuharik MA, Edwards MK, Farlow MR, Becker GJ, Azzarelli B, Klatte EC, Augustyn G, Dreesen RG (1988) Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions. AJNR Am J Neuroradiol 9:643-648
30. Lanens D, Van der Linden A, Gerrits PO, 's-Gravenmade EJ (1994) In vitro NMR microimaging of the spinal cord of chronic relapsing EAE rats. Magn Reson Imaging 12:469-475
31. Lassmann H, Ransohoff RM (2004) The CD4-th1 model for multiple sclerosis: A critical [correction of crucial] re-appraisal. Trends Immunol 25:132-137
32. Laule C, Vavasour IM, Moore GR, Oger J, Li DK, Paty DW, MacKay AL (2004) Water content and myelin water fraction in multiple sclerosis. A t2 relaxation study. J Neurol 251:284-293
33. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364:2106-2112
34. Li DK, Li MJ, Traboulsee A, Zhao G, Riddehough A, Paty D (2006) The use of MRI as an outcome measure in clinical trials. Adv Neurol 98:203-226
35. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
36. McFarland HI, Lobito AA, Johnson MM, Palardy GR, Yee CS, Jordan EK, Frank JA, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ (2001) Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis. J Immunol 166:2116-2121
37. Merkler D, Boretius S, Stadelmann C, Ernsting T, Michaelis T, Frahm J, Bruck W (2005) Multicontrast MRI of remyelination in the central nervous system. NMR Biomed 18:395-403
38. Morrissey SP, Deichmann R, Syha J, Simonis C, Zettl U, Archelos JJ, Jung S, Stodal H, Lassmann H, Toyka KV, Haase A, Hartung HP (1996) Partial inhibition of AT-EAE by an antibody to icam-1: clinico-histological and MRI studies. J Neuroimmunol 69:85-93
39. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV (1996) In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 119:239-248
40. Namer IJ, Steibel J, Klinguer C, Trifilieff E, Mohr M, Poulet P (1998) Magnetic resonance imaging of PLP-induced experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 92:22-28
41. Namer IJ, Steibel J, Poulet P, Armspach JP, Mauss Y, Chambron J (1992) In vivo dynamic MR imaging of MBP-induced acute experimental allergic encephalomyelitis in Lewis rat. Magn Reson Med 24:325-334
42. Namer IJ, Steibel J, Poulet P, Armspach JP, Mohr M, Mauss Y, Chambron J (1993) Blood-brain barrier breakdown in MBP-specific t cell induced experimental allergic encephalomyelitis. A quantitative in vivo MRI study. Brain 116:147-159
43. Nelson AL, Bieber AJ, Rodriguez M (2004) Contrasting murine models of MS. Int MS J 11:95-99
44. Noseworthy JH, Gilbert JJ, Vandervoort MK, Karlik SJ (1988) Postnatal NMR changes in guinea pig central nervous system: potential relevance to experimental allergic encephalomyelitis. Magn Reson Med 6:199-211
45. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
46. Noth U, Morrissey SP, Deichmann R, Jung S, Adolf H, Haase A, Lutz J (1997) Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif Cells Blood Substit Immobil Biotechnol 25:243-254
47. O'Brien JT, Noseworthy JH, Gilbert JJ, Karlik SJ (1987) NMR changes in experimental allergic encephalomyelitis: NMR changes precede clinical and pathological events. Magn Reson Med 5:109-117
48. Peersman GV, Van de Vyver FL, Lohman JE, Lubke U, Gheuens J, Bellon E, Connelly A, Martin JJ (1988) High resolution nuclear magnetic resonance imaging of the spinal cord in experimental demyelinating disease. Acta Neuropathol (Berl) 76:628-632
49. Piraino PS, Yednock TA, Freedman SB, Messersmith EK, Pleiss MA, Karlik SJ (2005) Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of alpha4 integrin. Mult Scler 11:683-690
50. Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, Johnson AJ, Hanson DP, Pease LR, Macura SI, Rodriguez M (2004) A human antibody that promotes remyelination, enters the Cns and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J 18:1577-1579
51. Pirko I, Fricke ST, Johnson AJ, Rodriguez M, Macura SI (2005) Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx 2:250-264
52. Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M (2004) Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage 21:576-582
53. Pirko I, Johnson A, Ciric B, Gamez J, Macura SI, Pease LR, Rodriguez M (2004) In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18:179-182
54. Pirko I, Johnson A, Gamez J, Macura SI, Rodriguez M (2004) Disappearing "t1 black holes" in an animal model of multiple sclerosis. Front Biosci 9:1222-1227
55. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "mcdonald criteria". Ann Neurol 58:840-846
56. Richards TL, Alvord EC Jr, Peterson J, Cosgrove S, Petersen R, Petersen K, Heide AC, Cluff J, Rose LM (1995) Experimental allergic encephalomyelitis in non-human primates: MRI and MRS may predict the type of brain damage. NMR Biomed 8:49-58
57. Rose LM, Richards TL, Peterson J, Petersen R, Alvord EC Jr (1997) Resolution of cns lesions following treatment of experimental allergic encephalomyelitis in macaques with monoclonal antibody to the cd18 leukocyte integrin. Mult Scler 2:259-266
58. Sriram S, Steiner I (2005) Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis. Ann Neurol 58:939-945
59. Stavraky RT, Grant CW, Barber KR, Karlik SJ (1993) Baseline consideration of liposomal contrast agent. CNS transport by macrophages in experimental allergic encephalomyelitis. Magn Reson Imaging 11:685-689
60. Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12-21
61. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK (2006) Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55:302-308
62. Xu S, Jordan EK, Brocke S, Bulte JW, Quigley L, Tresser N, Ostuni JL, Yang Y, McFarland HF, Frank JA (1998) Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using mion-46 1 enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 52:549-558
63. Yu O, Steibel J, Mauss Y, Guignard B, Eclancher B, Chambron J, Grucker D (2004) Remyelination assessment by MRI texture analysis in a cuprizone mouse model. Magn Reson Imaging 22:1139-1144
64. Zamaroczy D, Schluesener HJ, Jolesz FA, Sobel RA, Colucci VM, Weiner HL, Sandor T (1991) Differentiation of experimental white matter lesions using multiparametric magnetic resonance measurements. Invest Radiol 26:317-324
65. Zivadinov R, Bakshi R (2004) Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci 9:665-683
66. Zivadinov R, Bakshi R (2004) Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci 9:647-664